Insta
Delhi HC Quashes Centre’s Ban On 344 FDC Medicines After Pharma Company Petitions
An Indian pharmacy shop assistant counts a strip of tablets. Photo credit: DESHAKALYAN CHOWDHURY/AFP/Getty Images
The Delhi High Court on Thursday (1 December) quashed the centre's notification to ban 344 fixed dose combination (FDC) medicines. The brands included D'Cold Total, Corex cough syrup and Vicks Action 500, among others.
Justice R S Endlaw, allowing the 454 pleas filed by the pharma companies, quashed the centre's notification issued on 10 March. Companies like Pfizer, Glenmark, Procter and Gamble, Reckitt Benckiser, Cipla and others had moved the court against the government’s decision. The court had granted stay on the notification.
The government had told the court that FDC medicines sold by pharma majors "endanger patient safety". It had banned the drugs on the ground that they involve risk to humans and, therefore, needed to be withdrawn immediately and contended that safer alternatives were available.
The pharma companies had argued that the ban order was passed without considering clinical data and had termed the government's claim as absurd.
With inputs from IANS
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest
